These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2023194)

  • 1. Longterm cyclosporine therapy in rheumatoid arthritis.
    van Rijthoven AW; Dijkmans BA; Goei Thè HS; Boers M; Cats A
    J Rheumatol; 1991 Jan; 18(1):19-23. PubMed ID: 2023194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis.
    Boers M; Dijkmans BA; van Rijthoven AW; Goei Thè HS; Cats A
    J Rheumatol; 1990 Jan; 17(1):38-42. PubMed ID: 2179550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients.
    Boers M; van Rijthoven AW; Goei Thè HS; Dijkmans BA; Cats A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):371-5. PubMed ID: 3289212
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
    Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
    J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis.
    Landewe RB; Goei The HS; van Rijthoven AW; Rietveld JR; Breedveld FC; Dijkmans BA
    J Rheumatol; 1994 Sep; 21(9):1631-6. PubMed ID: 7799340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.
    Boers M; Bensen WG; Ludwin D; Goldsmith CH; Tugwell P
    J Rheumatol; 1992 Apr; 19(4):534-7. PubMed ID: 1593573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.
    van den Borne BE; Landewé RB; Goei The HS; Rietveld JH; Zwinderman AH; Bruyn GA; Breedveld FC; Dijkmans BA
    J Rheumatol; 1998 Aug; 25(8):1493-8. PubMed ID: 9712089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis.
    Madhok R; Torley HI; Capell HA
    J Rheumatol; 1991 Oct; 18(10):1485-9. PubMed ID: 1765972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
    Johns KR; Littlejohn GO
    J Rheumatol; 1999 Oct; 26(10):2110-3. PubMed ID: 10529125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with cyclosporine of refractory rheumatoid arthritis].
    Massardo L; Jacobelli S; Figueroa F; Gutiérrez F; Martínez ME; Rivero S
    Rev Med Chil; 1995 Feb; 123(2):215-24. PubMed ID: 7569462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
    Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
    Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
    J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.